SOBRE ESTE EPISÓDIO
Host: John Buse, MD, PhD
Guest: Steven Russell, MD, PhD
Guest: Steven Russell, MD, PhD
Research continues to emerge on the bionic pancreas and its capabilities, and a recent study shows how it can count carbohydrates and lower A1c for patients with type 1 diabetes. To find out how it does, Dr. John Buse is joined by Dr. Steven Russell, an Associate Professor of Medicine at Harvard Medical School at the Massachusetts General Hospital.
Inglês
Estados Unidos da América
NESTE EPISÓDIO
TRANSCRIÇÃO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de Diabetes Discourse.
OUTROS EPISÓDIOS NESTE PODCAST
Guest: John W. Ostrominski, MD, MPH
Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face substantial residual cardiovascular risk. In this program,…
Guest: Javier Morales, MD, FACP, FACE
For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales sha…
Guest: Javier Morales, MD, FACP, FACE
From proactive screening to once-weekly insulin, the treatment landscape for type 1 diabetes is evolving rapidly. Join Dr. Javier Morales to hear about current and emerging care strategies in these patients, a topic he also discussed at the 2026 Amer…
Host: Steve Jackson, PharmD
Guest: Souptik Barua, PhD
Guest: Emily Johnston, MPH, PhD
Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston an…
Guest: Kimberly Narain, MD, MPH, PhD
Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr. Kimberly Narain joins us to explain why clinicians sho…
Aviso: O podcast e a arte incorporada nesta página são de ReachMD, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.
